Loading...
Emodin enhances cisplatin sensitivity in non-small cell lung cancer through Pgp downregulation
Cisplatin resistance is one of the main causes of chemotherapy failure and tumor progression in non-small cell lung cancer (NSCLC). Emodin has been demonstrated to induce NSCLC cell apoptosis and act as a potential cancer therapeutic agent. However, whether emodin could affect NSCLC cell sensitivity...
Na minha lista:
| Udgivet i: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7856686/ https://ncbi.nlm.nih.gov/pubmed/33613719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2021.12491 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|